KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Non-Current Debt (2016 - 2025)

Merck (MRK) has disclosed Non-Current Debt for 17 consecutive years, with $46.8 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 35.66% to $46.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $46.8 billion, a 35.66% increase, with the full-year FY2025 number at $46.8 billion, up 35.66% from a year prior.
  • Non-Current Debt was $46.8 billion for Q4 2025 at Merck, up from $40.0 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $46.8 billion in Q4 2025 to a low of $22.9 billion in Q3 2021.
  • A 5-year average of $31.9 billion and a median of $32.3 billion in 2024 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: decreased 12.97% in 2021, then surged 35.66% in 2025.
  • Merck's Non-Current Debt stood at $30.7 billion in 2021, then decreased by 6.34% to $28.7 billion in 2022, then rose by 17.18% to $33.7 billion in 2023, then increased by 2.31% to $34.5 billion in 2024, then surged by 35.66% to $46.8 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Non-Current Debt are $46.8 billion (Q4 2025), $40.0 billion (Q3 2025), and $34.0 billion (Q2 2025).